Skip to main content
Enrolls caregiversCaregiver StressBehavioralBehavioral

What this study is

The goal of this study is to evaluate the efficacy of group-based ACT intervention in improving the levels of psychological distress in caregivers of stroke survivors. The main questions it aims to answer are:

1. Does group-based ACT intervention improve the levels of psychological distress and QoL in family caregivers of stroke survivors? 2. Do the levels of psychological flexibility and experiential avoidance in family caregivers of stroke survivors mediate the outcome of the ACT Group?

The researcher will compare the experimental group (i.e., participants who received group-based ACT intervention) with the control group (i.e., participants who did not receive group-based ACT intervention) to assess whether the group-based ACT intervention is effective in mitigating caregiver stress and improving caregivers' QoL.

Participants in the experimental group will:

1. Receive a 5-weekly, 1.5-hour group intervention based on the ACT Model; 2. Complete study measures at pre-treatment, immediate post-treatment, and 2-month follow-up.

Participants in the control group will not receive the group intervention but will complete the same study measures.

What's being tested

  • Group-based ACT Intervention

    Intervention · BEHAVIORAL

    5-weekly, 1.5-hour group intervention based on the ACT Model

Study details

Official title
Effects of Acceptance and Commitment Therapy (ACT) Group for Family Caregivers of Stroke Survivors
Sponsor
The Wright Institute
Conditions
Caregiver Stress · Caregiver Stress Syndrome · Caregiver Burnout · Caregiver Distress · Caregiver Exhaustion · Caregiver Health Related QOL · Caregiver Burden for Those Who Care for Adults With Impaired Functional Status · Caregiver Quality of Life · Caregiver Burden · Caregiver Mental Health · Caregiver Resilience and Stress · Caregiver Sense of Control Over Life · Caregiver Awareness · Caregiver Stress in Chronic Mental Illness
Enrolling
30 people
Starts
2025-09-01
Est. completion
2028-05-31
Design
Single-blind, non-randomized, parallel groups
Record
View on ClinicalTrials.gov ↗